Mar 05, 2024 / 02:10PM GMT
Stephen Michael Scala - TD Cowen, Research Division - MD & Senior Research Analyst
Okay. So. Thank you and good morning. Thanks for (inaudible). We're delighted to have AbbVie at 44th Annual Healthcare Conference and representing the company, we have a number of members of management. Rob Michael, who is President and COO; and of course, incoming CEO; Jeff Stewart, who is Executive Vice President and Chief Commercial Officer; and Roopal Thakkar, who is Senior Vice President Chief Medical Officer of Global Therapeutics. Also here is Scott Reents, who is Executive Vice President and CFO. So thank you so much for making the journey lots to talk about at AbbVie. There's always great stuff going on.
But let's start out with kind of a big picture, Rob -- a question, Rob. So as the incoming CEO, what should investors expect relative to changes at AbbVie, if any?
Questions and Answers:
Robert A. Michael - AbbVie Inc. - President & COOWell, Steve, as you know, I've been with AbbVie since our inception. So my goal is to make it as seamless as
Trustpilot
